Showing results (1-10 of 451) with videos related to
Sort By:
Pageof 46
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Vaccination of patients with solid tumoursG Parmiani, L Pilla, C Castelli, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2006
Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patientsG Parmiani, C Castelli, L Pilla, et al.International Journal of Clinical & Laboratory Research|January 1, 1997
T-cell recognition of melanoma antigens and its therapeutic applicationsC Castelli, L Rivoltini, A Mazzocchi, et al.Journal of Cellular Physiology|February 1, 2000
T-cell recognition of melanoma-associated antigensC Castelli, L Rivoltini, G Andreola, et al.European Journal of Cancer & Clinical Oncology|January 1, 1989
In vitro lymphocyte response to autologous melanoma: clues in designing new adoptive immunotherapy protocolsG Parmiani, L RivoltiniCurrent Opinion in Oncology|December 1, 1991
Biologic agents as modifiers of chemotherapeutic effectsG Parmiani, L RivoltiniCancer Research|February 24, 2001
Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cellsC Castelli, A M Ciupitu, F Rini, et al.Immunology Letters|September 21, 2000
Cytokines in cancer therapyG Parmiani, L Rivoltini, G Andreola, et al.Cancer Immunology, Immunotherapy : CII|July 19, 2001
Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cells to be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytesA Mazzocchi, C Melani, L Rivoltini, et al.European Journal of Immunology|May 16, 1998
Immunogenicity of the ALLAVGATK (gp100[17-25]) peptide in HLA-A3.1 melanoma patientsC Castelli, A Mazzocchi, F Rini, et al.Pageof 46